# INTEGRA LIFESCIENCES HOLDINGS CORP (IART) FY2026 Q2 Balance Sheet

- Company: INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-29, accession number 0000917520-26-000058
- Page: https://plicit.ai/financials/iart/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/iart-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 3,563,490,000 US dollars
- **Current assets**: 1,191,482,000 US dollars
- **Non-current assets**: 2,372,008,000 US dollars
- **Liabilities**: 2,520,113,000 US dollars
- **Current liabilities**: 330,881,000 US dollars
- **Non-current liabilities**: 2,189,232,000 US dollars
- **Equity**: 1,043,377,000 US dollars
- **Inventories, net**: 492,005,000 US dollars
- **Trade accounts receivable, net of allowances of $7,326 and $7,230**: 267,188,000 US dollars
- **Cash and cash equivalents**: 214,415,000 US dollars
- **Prepaid expenses**: 104,344,000 US dollars
- **Short-term investments**: 59,669,000 US dollars
- **Other current assets**: 53,861,000 US dollars
- **Intangible assets, net**: 1,075,542,000 US dollars
- **Goodwill**: 611,145,000 US dollars
- **Property, plant and equipment, net**: 446,202,000 US dollars
- **Right of use asset - operating leases**: 137,085,000 US dollars
- **Deferred tax assets, net**: 70,443,000 US dollars
- **Other assets**: 31,591,000 US dollars
- **Accrued expenses and other current liabilities**: 107,618,000 US dollars
- **Accounts payable, trade**: 82,637,000 US dollars
- **Accrued compensation**: 68,177,000 US dollars
- **Current portion of borrowings under senior credit facility**: 43,594,000 US dollars
- **Current portion of lease liability - operating leases**: 13,920,000 US dollars
- **Contract liabilities**: 11,699,000 US dollars
- **Income tax payable**: 3,236,000 US dollars
- **Current portion of borrowings under securitization facility**: 0 US dollars
- **Long-term borrowings under senior credit facility**: 1,736,105,000 US dollars
- **Other liabilities**: 194,397,000 US dollars
- **Lease liability - operating leases**: 162,660,000 US dollars
- **Long-term borrowings under securitization facility**: 92,600,000 US dollars
- **Deferred tax liabilities**: 3,470,000 US dollars
- **Additional paid-in capital**: 1,346,265,000 US dollars
- **Retained earnings**: 423,306,000 US dollars
- **Common stock; $0.01 par value; 240,000 authorized shares; 92,130 and 92,286 issued at June 30, 2026 and December 31, 2025, respectively**: 921,000 US dollars
- **Preferred stock; no par value; 15,000 authorized shares; none outstanding**: 0 US dollars
- **Treasury stock, at cost; 14,351 shares and 14,399 shares at June 30, 2026 and December 31, 2025, respectively**: negative 686,918,000 US dollars
- **Accumulated other comprehensive loss**: negative 40,197,000 US dollars
- **Gross equity (calculated)**: 1,770,492,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.